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Abstract
The capacity to monitor spatiotemporal activity of phospholipase C (PLC) isozymes with a PLC-
selective sensor would dramatically enhance understanding of the physiological function and
disease relevance of these signaling proteins. Previous structural and biochemical studies defined
critical roles for several of the functional groups of the endogenous substrate of PLC isozymes,
phosphatidylinositol 4,5-bisphosphate (PIP2), indicating that these sites cannot be readily modified
without compromising interactions with the lipase active site. However, the role of the 6-hydroxy
group of PIP2 for interaction and hydrolysis by PLC has not been explored, possibly due to
challenges in synthesizing 6-hydroxy derivatives. Here, we describe an efficient route for the
synthesis of novel, fluorescent PIP2 derivatives modified at the 6-hydroxy group. Two of these
derivatives were used in assays of PLC activity in which the fluorescent PIP2 substrates were
separated from their diacylglycerol products and reaction rates quantified by fluorescence. Both
PIP2 analogues effectively function as substrates of PLC-δ1, and the KM and Vmax values
obtained with one of these are similar to those observed with native PIP2 substrate. These results
indicate that the 6-hydroxy group can be modified to develop functional substrates for PLC
isozymes, thereby serving as the foundation for further development of PLC-selective sensors.
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The phospholipase C (PLC) family of enzymes catalyze the hydrolysis of membrane-bound
phosphatidylinositol 4,5-bisphosphate (PIP2) to form the second messengers, diacylglycerol
(DAG) and inositol 1,4,5-trisphosphate (IP3).1 Diacylglycerol activates protein kinase C
(PKC) while IP3 activates calcium channels leading to the release of Ca2+ from endothelial
reticulum to cytosol.2 In addition, PLC action also regulates local PIP2 pools leading to
changes in subcellular localization and/or function of a broad range of PIP2-interacting
proteins, including numerous ion channels. Consequently, PLCs are essential signaling
proteins that regulate diverse cellular processes, including proliferation3 and differentiation,4
vasculogenesis,5 and fertilization.6 Aberrant regulation of PLCs has been implicated in
diseases including cancer,7–13 heart diseases,14 and neuropathic pain.15
The 13 mammalian PLC isozymes are broadly grouped into six families (−β, −γ, −δ, −ε,
−ζ, −η) based on their sequence homologies and functions. Various extracellular stimuli
activate different PLC isoforms through distinct mechanisms. For example, agonists of G-
protein coupled receptors (GPCRs) activate PLC-β isozymes through Gαq- and Gβγ-
subunits of heterotrimeric G proteins, while PLC-γ activity is enhanced through
phosphorylation promoted by receptor and non-receptor tyrosine kinases. In addition, PLC-ε
and certain members of the PLC-β and PLC-γ subclasses of isozymes are activated by Ras,1
Rho,17 and Rac subfamilies of small GTPases.18 However, when, where, and how various
PLC isoforms are activated under different extracellular stimuli are still not well understood.
This is partly due to the lack of methods to monitor the spatiotemporal activities of cellular
PLCs.
Standard, radioisotope-based assays are discontinuous and cannot be used to monitor the
real-time dynamics of PLC activity in cells. Cell permeable dyes that increase in
fluorescence upon binding calcium are also routinely used as complementary methods to
monitor PLC activity. However, although such assays are simple and throughput is high,
they are not a direct measure of PLC activity and often generate confounding data since
other factors also contribute to intracellular calcium concentration.
With the long-term goal of spatiotemporal monitoring of inositol lipid signaling, we initiated
studies to develop small molecule sensors of PLCs. Previous kinetic studies demonstrated
that the 2-hydroxy (2-OH) in PIP2 is essential19–21 for its hydrolysis by PLCs and that 3-
phosphoinositides are not PLC substrates.22 Similarly, removal of the phosphate group from
the 4- or 5-OH positions resulted in derivatives that are poor substrates for PLCs.
Furthermore, the stereochemistry of the D-myo-insoitol headgroup, but not the diacylglycerol
side chain, was shown to be critical for effective PLC-mediated catalysis.23 Finally, alkyl
substitutions at the sn-1 and sn-2 positions resulted in PIP2 molecules that still function as
PLC substrates.24 In general, the longer the side chain, the more efficient the corresponding
PIP2 derivative was for PLC-promoted hydrolysis.25 These results are supported by the
crystal structure26,27 of the catalytic domain of PLC-δ1 in complex with IP3; the 1-, 4-, and
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5-phosphates and the 2- and 3-hydroxyls of IP3 interact with PLC-δ1, and mutation of these
interacting residues greatly reduced the capacity of PLC-δ1 to hydrolyze PIP2.28
Consequently, modifications of PIP2 to develop new PLC substrates have avoided targeting
the inositol headgroup and have instead focused on the diacylglycerol side chain. For
example, we29 and others30–33 have developed fluorogenic PLC reporters with
modifications at the 1-phosphate to monitor PLC activity in vitro. However, these systems
are unlikely to be optimal for studies in live cells since potential spatial information on PLC
activity will be lost upon cleavage of the fluorophore from the PIP2 derivative.
To our knowledge, selective modification of the 6-OH has not been explored despite
extensive previous efforts synthesizing PIP2 analogues for novel functions and assays. The
structure of PLC-δ1 bound to IP3 highlights a lack of direct interaction between the lipase
active site and the 6-OH group, indicating that the 6-OH is solvent exposed and its
modification in PIP2 is likely tolerated within the active site of PLCs. Consequently, we
designed and synthesized three PIP2 derivatives (Figure 1) and investigated their capacity to
be hydrolyzed by PLC-δ1. Probe 1 has a free 6-OH identical to endogenous PIP2 while
probes 2 and 3 have modified 6-OH groups, with a propyl modification in 2 and an extended
hydroxy in 3. The incorporation of a fluorescent group at the sn-1 position of the DAG side
chain provides a sensitive detection of both the substrate and the product by fluorescence,
thus avoiding the use of radioactive materials and providing a potential avenue for the use of
realtime monitoring of phospholipase activity in cells with high spatiotemporal resolution
and high throughput.
EXPERIMENTAL PROCEDURES
Kinetic Studies of Probes 1–3
Enzymatic Reactions—The fluorescent PIP2 derivatives were dissolved in water to make
working solutions at 432, 324, 216, 108, 54, 32, 24, or 12 µM. To these solutions (20 µL)
were added a 6X buffer (5 µL) that contains HEPES (300 mM, pH 7.2), KCl (420 mM),
CaCl2 (17.8 mM), EGTA (18 mM), DTT (12 mM), and 3% cholate. The reaction was
initiated by adding a solution (5 µL) that contains purified, full-length PLC-δ1 (0.05 or 0.1
ng/µL, final concentration) and BSA (1 mg/mL), and the reaction mixtures were incubated at
25 °C. At indicated time points, samples were taken out of the reaction mixtures with a
multichannel pipet (1 µL) and spotted on TLC plates (Merck, Silica Gel-60). The TLC plates
were then developed with CHCl3:MeOH:H2O (100:20:1) and scanned with a Typhoon 9400
Variable Mode Imager (λex/λem = 488 nm/520 nm). The fluorescence of DAG and PIP2
derivatives on the TLC plate was quantified with ImageQuant software (V.5.0).
Fluorescence Calibration and Reaction Rate Calculation—To a set of water
solutions (20 µL) containing various concentrations (432, 324, 216, 108, 54, 32, 24, and 12
µM) of PIP2 derivative 1 was added the 6X buffer solution (5 µL) as defined previously and
a PLC solution (5 µL) containing purified, full-length PLC-δ1 (10 ng/µL, final
concentration) and BSA (1 mg/mL). The reaction mixtures were incubated at 25 °C for 2 h
to completely convert probe 1 to DAG. As a control, the reactions were also carried out in
the presence of BSA (PLC free). These two sets of reaction mixtures were spotted on TLC
plates which were subsequently developed and the fluorescence was quantified. The
fluorescence was plotted against concentration for probe 1 or DAG. The slope of the plot for
probe 1 was 0.66-fold of that for DAG. Consequently, the amount of DAG that was
generated from the reaction was calculated with the formula
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where a = fluorescence of DAG and b = fluorescence of PIP2.
Kinetic Studies of Endogenous PIP2
A mixture of PIP2 (Avanti Polar Lipids) and 30 000 cpm of [3H]PIP2 (Perkin-Elmer) was
dried under a stream of nitrogen and resuspended in assay buffer that contains HEPES (50
mM, pH 7.2), KCl (70 mM), EGTA (3 mM), DTT (2 mM), CaCl2 (2.96 mM), 0.5% cholate,
and BSA (0.2 mg/mL). The resulting lipid stock was diluted to obtain final assay conditions
with either 216, 144, 72, 36, 24, 16, 8, or 4 µM PIP2 in assay buffer (50 µL, final volume).
Assays were initiated by the addition of purified, full-length PLC-δ1 (0.075 ng) in assay
buffer (10 µL). After incubation at 25 °C for 10 min, reactions were stopped by the addition
of 10% (v/v) trichloroacetic acid (200 µL) and 10 mg/mL BSA (100 µL) to precipitate
proteins and uncleaved lipids. Centrifugation of the reaction mixture isolated soluble [3H]
IP3, which was quantified using liquid scintillation counting.
RESULTS AND DISCUSSION
1. Synthesis of the Fluorescent Probes
Fluorescent PIP2 derivatives with free 6-OH such as 1 have been used to image cellular PIP2
localization34 and as probes for metabolic enzymes such as phosphoinositide 3-kinase
(PI3K).35 Consequently, the synthesis of 1 follows the literature procedure.36–38 In contrast,
PIP2 analogues with 6-OH selectively modified have not been reported and their syntheses
are challenging. To synthesize the probe 2 (Scheme 1) with 6-OH group protected as its
propyl ether, we started with the known inositol derivative 4. Alkylation of 4 with allyl
bromide followed by deacetalization with trifluoroacetic acid (TFA) generated 5 in 74%
yield. The diol in 5 was subsequently protected as the corresponding methoxymethyl
(MOM) ethers. Next, the corresponding methoxymethyl (MOM) ethers. Next, the
tetraisopropyldisiloxane (TIPDS) group was removed by treating with hydrofluoride (HF) in
CHCl3/CH3CN. The resulting hydroxy groups were phosphorylated to form 7 in a two-step
sequence: first reacted with dibenzyl diisopropylphosphoramidite in the presence of
tetrazole and then oxidized by 3-chloroperoxybenzoic acid (mCPBA). The tert-
butyldiphenylsilyl (TBDPS) protection was removed by tetrabutylammonium fluoride
(TBAF) to form alcohol 8, which was coupled to the diacylglycerol side chain 9 to form 10
in 90% yield through phosphorylation followed by oxidation with tert-butyl peroxide (t-
BuOOH). To remove the MOM protective groups, compound 10 was treated with
trimethylsilyl bromide (TMSBr) in CH2Cl2 followed by methanolysis. The benzyl protective
groups were also partially removed during this process. Hydrogenolysis completed the
deprotection of both benzyl and carbobenzyloxy (Cbz) groups and reduced the allyl to
propyl group to form 11. Finally, the terminal amine was acylated with activated fluorescein
12 to generate the fluorescent PIP2 derivative 2 with 6-OH capped as a propyl ether. The
overall yield of the synthesis was 37%.
To synthesize the probe 3 (Scheme 2), olefin metathesis of 6 with MOM-protected allylic
alcohol was carried out. We did not attempt to quantify the E/Z ratio although the formed
double bond had predominantly the E configuration as judged by NMR. Instead, the olefin
was directly subjected to hydrogenation to form 13. In a sequence that is analogous to the
synthesis of probe 2, the diol 13 was used to generate probe 3. The overall yield of this
sequence was 15%.
2. Thin-Layer Chromatography Coupled with Fluorescence Scanning as a New Assay for
PLC Activity
The classical in-vitro assay of PLC activity requires the use of radioactive PIP2, particularly
tritium-labeled PIP2, as the PLC substrate. To avoid the use of radioactive PIP2, 31P NMR
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has been used to monitor PLC-catalyzed reactions.39 However, the concentration of PIP2 has
to be high (>0.5 mM) to obtain accurate measurement, and these techniques are not
amenable to large numbers of samples. Existing fluorogenic 31,32 and luminescence-based33
reporters have the advantage of continuous monitoring of PLC activity with high sensitivity.
However, these reporters typically replace the diacylglycerol unit connected to the 1-
phosphate in PIP2, thereby limiting their utility to faithfully recapitulate intracellular events.
In contrast, 6-OH analogues provide unexplored potential to produce useful biosensors of
PLC activity in cells.
The fluorescent PIP2 derivative 1 has key structural features of endogenous PIP2 including
an identical inositol phosphate headgroup and a diacylglycerol side chain. Derivative 1 and
its expected PLC-dependent hydrolysis products (Figure 2A) are predicted to be readily
separable by either TLC or column chromatography, and subsequent detection by
fluorescence should provide a new assay for PLC activity. To validate this format, purified
PLC-δ1 was used to hydrolyze probe 1. Based on sequence and structural similarities, the
catalytic domain of PLC-δ1 is representative of the entire family of PLC isozymes. The
enzymology of PLC-δ1 has also been extensively studied2026,28,40–42, benefits from the
unique structure of PLC-δ1 bound to IP3 within its active site. The purified enzyme was
incubated with probe 1 at room temperature for 10 min, and the mixture was separated on
TLC and detected by fluorescence. Fluorescence at the origin of application represents probe
1 and a second fluorescent component appeared as a function of increasing amounts of time
during the initial incubation (Figure 2B). This new component was confirmed by LC-MS
analysis to be the diacylglycerol derivatives predicted to be generated upon hydrolysis of
probe 1 by PLC-δ1. When probe 1 was incubated with catalytically inactive PLC-δ1
(E341A),28 no new fluorescent components were formed (Figure 2B), indicating that the
hydrolysis of 1 is dependent on the lipase activity of PLC-δ1.
Conditions were established to quantify the fluorescent DAG derivative formed during the
reaction. Briefly, the linear plots of the fluorescence versus concentration for both 1 and the
corresponding DAG product are shown in Figure 2C. The ratio of the slopes was used as the
coefficient to normalize fluorescence readings for quantifications. Accordingly, 8% of probe
1 was converted to product in Figure 2B. Under identical conditions, 3% and 5% of probes 2
and 3 were converted to product, respectively. Like probe 1, probes 2 and 3 were not
cleaved by catalytically inactive PLC-δ1 (E341A) suggesting that both are selective
substrates for PLC-δ1.
3. Kinetic Studies of Probes 1–3 with PLC-δ1
As highlighted in Figure 2B, probes 1–3 were cleaved by PLC-δ1 with different efficiencies.
To further define these probes as PLC substrates for future development of PLC sensors, we
carried out detailed kinetic studies to measure KM and Vmax of these probes in PLC-
catalyzed reactions. For comparison, enzyme kinetics using PIP2 as the substrate were
quantified as previously described43 by varying the bulk concentration of [3H]PIP2-
containing vesicles.
To increase the efficiency and accuracy of the kinetic measurements, we carried out the
experiments with probes 1–3 in a 96-well plate (Figure S1). At the indicated time, the
samples were taken from reaction mixtures with a multichannel pipet and loaded directly
onto the TLC plates. The fluorescent components in the reaction mixture were then
separated and quantified by fluorescence. All the measurements were under initial rate
conditions (Figures S2). KM and Vmax were then calculated by fitting the data to the
Michaelis—Menten equation (Figure 3A,c,). The KM for probe 1 was 39 ± 4.0 µM with a
Vmax of 94 ± 0.9 pmol/(ng min) while the KM for probe 2 was 67 ± 9.6 µM with a Vmax of
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32 ± 1.8 pmol/(ng min). Capping of the 6-OH with a propyl group decreased Vmax and
increased KM, suggesting that the modification at 6-OH might interfere with the key
interactions of other substitutions in the inositol headgroup with PLC-δ1. In addition, the
propyl group may increase the steric hindrance around the 1-phosphate, making the PLC-
catalyzed nucleophilic addition of the 2-OH to the 1-phosphate a slower process.
Interestingly, relative to probe 2, probe 3 further increased KM (128 ± 15.3 µM) while
having a less detrimental effect on Vmax (67 ± 9.6 pmol/(ng min)), suggesting that
increasing the length of the substitution at the 6-OH disrupts interactions with PLC-δ1 while
the terminal hydroxy of the substitution may participate in substrate-assisted catalysis to
facilitate phospholipase activity. In both cases, the KM and Vmax of 2 and 3 are within a 3-
fold range of equivalent values for probe 1, which are similar to those for the endogenous
PIP2 (Figure 3B,C). Consequently, modifying the 6-OH generate functional PIP2 derivatives
that potentially can be applied to monitor PLC activity spatiotemporally.
CONCLUSION
In conclusion, we have developed an efficient synthesis to prepare PIP2 derivatives modified
at the 6-hydroxy group, making it possible to explore the role of the 6-OH in PIP2 for PLC-
catalyzed hydrolysis. Several of these derivatives have been characterized in a new TLC-
based assay that features straightforward separation of products from the reaction mixture
and sensitive detection for their capacity as substrates of PLC-δ1. These modifications at the
6-OH group result in derivatives that are excellent PLC substrates with marginally lower
Vmax and higher KM values compared to the unmodified parent PIP2 derivative and
endogenous PIP2. These results demonstrate that the 6-OH group can be modified for new
functions, setting the stage for further development of sensors selective for PLC isozymes
and useful for monitoring the spatiotemporal dynamics of these enzymes in living cells.
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Chemical structures of the PIP2 derivatives 1–3 as PLC substrates.
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Validation of the TLC-fluorescence assay. (A) Probes 1–3 are cleaved by PLC-δ1 to form
inositol trisphosphate and diacylglycerol (DAG) derivatives. (B) The separation of PIP2
derivatives 1–3 and their corresponding DAGs on thin-layer chromatography (TLC). The
reaction mixture (1 µL) was spotted on the TLC plate and separated by CHCl3:MeOH:H2O
(100:20:1). The fluorescent compounds were detected by a Typhoon 9400 variable mode
imager (λex/λem = 488 nm/520 nm). (C) Plot of fluorescence versus concentration of DAG
or probe 1.
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Kinetic studies of probes 1–3 or endogenous PIP2 with PLC-δ1. (A) The initial velocities of
hydrolysis of 1, 2, or 3 at various concentrations were fitted to the Michaelis—Menten
equation. (B) Hydrolysis rates of PIP2 at various concentrations were fitted to the Michaelis
—Menten equation. (C) KM and Vmax of probes 1–3 and endogenous PIP2 with PLC-δ1.
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Synthesis of Probe 2
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Synthesis of Probe 3
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